Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
JOURNAL OF CLINICAL ONCOLOGY
Kantarjian, HM; Thomas, XG; Dmoszynska, A; Wierzbowska, A; Mazur, G; Mayer, J; Gau, JP; Chou, WC; Buckstein, R; Cermak, J; Kuo, CY; Oriol, A; Ravandi, F; Faderl, S; Delaunay, J; Lysak, D; Minden, M; Arthur, C, 2012: Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia. JOURNAL OF CLINICAL ONCOLOGY 30(21), p. 2670 - 2677, doi: 10.1200/JCO.2011.38.9429
CEITEC authors: